Henogen: Clinical Trials

2 trials sponsored by Henogen, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 withdrawn. 2 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Withdrawn 1
Phase 11Withdrawn 1

Follow Henogen: new trials by email

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Anti-CD3 & Anti-CD7 Ricin A Immunotoxin-Combination for Acute Graft Versus Host Disease
IT-Combination - Acute Graft Versus Host Disease
Phase 1 / Phase 2WithdrawnHenogen122010-01-012009-04-29
Evaluation of Safety, Immune-Response and Efficacy of GSK Biologicals' EBV (Epstein Barr Virus) Vaccine (268664).
EBV vaccine (268664) - Epstein Barr Virus (EBV) Infection
Phase 2CompletedHenogen2002007-02-02

Conditions studied

Epstein-Barr Virus Infections (1)  ·  Infections (1)  ·  Infectious Mononucleosis (1)

Countries

Belgium (1)  ·  Netherlands (1)

Top investigators

Anton V Schattenberg,, MD, PhD, (1)

Results publications

PMID 18190254